D268-0425 Screening compound: 4-({6-[(2-fluorophenyl)amino]-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl}amino)-1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one

D268-0425 Screening compound: 4-({6-[(2-fluorophenyl)amino]-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl}amino)-1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one
D268-0425 Screening compound: 4-({6-[(2-fluorophenyl)amino]-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl}amino)-1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one alternative view

Chemical Structure Depiction of ChemDiv screening compound D268-0425
4-({6-[(2-fluorophenyl)amino]-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl}amino)-1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D268-0425

Molecular Formula

C21H17FN8O2 (C21 H17 FN8 O2)

Compound Name

4-({6-[(2-fluorophenyl)amino]-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl}amino)-1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one

IUPAC name

4-({6-[(2-fluorophenyl)amino]-[125]oxadiazolo[34-b]pyrazin-5-yl}amino)-15-dimethyl-2-phenyl-23-dihydro-1H-pyrazol-3-one

SMILES

CC(N(C)N(C1=O)c2ccccc2)=C1Nc1nc2nonc2nc1Nc(cccc1)c1F

InChI

InChI=1S/C21H17FN8O2/c1-12-16(21(31)30(29(12)2)13-8-4-3-5-9-13)24-18-17(23-15-11-7-6-10-14(15)22)25-19-20(26-18)28-32-27-19/h3-11H,1-2H3,(H,23,25,27)(H,24,26,28)

InChI Key

DTUOOAUMIWGTOF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00324564

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

432.42

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.224

Distribution Coefficient, logD

1.396

Water Solubility, LogSw

-3.45

Polar Surface Area

94.229

Acid Dissociation Constant (pKa)

5.58

Base Dissociation Constant (pKb)

-10.18

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

9.50

D268-0425 in Drug Discovery

Included in Screening Libraries

C-Met Library (15277 compounds)

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

New Agro Library (44492 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Immune system
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • Receptor's ligands
Agro:
  • Agro

References: we are preparing a list of scientific research reports with D268-0425 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D268-0425?
Check Price and Availability of D268-0425, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D268-0425 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D268-0425
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D268-0425
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D268-0425 available by request